Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126813172 | 12681317 | 2 | F | 20160704 | 20160829 | 20160824 | 20160907 | EXP | US-SA-2016SA149869 | AVENTIS | 57.00 | YR | A | F | Y | 0.00000 | 20160907 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126813172 | 12681317 | 1 | PS | AMBIEN | ZOLPIDEM TARTRATE | 1 | Unknown | U | UNKNOWN | 19908 | |||||||||
126813172 | 12681317 | 2 | SS | XANAX | ALPRAZOLAM | 1 | Unknown | U | UNKNOWN | 0 | |||||||||
126813172 | 12681317 | 3 | SS | SOMA | CARISOPRODOL | 1 | Oral | Y | UNKNOWN | 0 | |||||||||
126813172 | 12681317 | 4 | SS | ATIVAN | LORAZEPAM | 1 | Oral | Y | UNKNOWN | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126813172 | 12681317 | 3 | Myalgia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126813172 | 12681317 | OT |
126813172 | 12681317 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126813172 | 12681317 | Abasia | |
126813172 | 12681317 | Coma | |
126813172 | 12681317 | Dysphagia | |
126813172 | 12681317 | Hypotonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126813172 | 12681317 | 3 | 20160704 | 0 | ||
126813172 | 12681317 | 4 | 20160704 | 0 |